Dr Sarah Brüningk  is a group leader for paediatric oncology applications within the Biomedical Data Science lab of Prof Catherine Jutzeler at ETH Zurich. Her expertise in both practical biological lab work and computational implementations enables her to pursue challenging multidisciplinary projects at the interface of computational biology, machine learning and oncology. Her research interests lie in combining machine learning and mechanistic modelling for healthcare applications embracing the clinical hallmarks of a disease in order to provide interpretable and deployable healthcare solutions. Before joining ETH Zurich, Dr Brüningk completed her PhD at the Institute of Cancer Research in London, UK, on the analysis and simulation of combination treatments of radiation and focused ultrasound-mediated heating. Her work has previously been recognized by several travel, poster and presentation awards, as well as the Nadine Barrie Smith Student Award and the Sensius Young Investigator Award.

Dr Brüningk leads the BRCCH project: Harnessing Machine Learning and Mechanistic Modelling for Personalised Radiotherapy of Paediatric Diffuse Midline Glioma. Read more here.

Dr Gillian Levine is an epidemiologist and a Basel Research Centre for Child Health Postdoctoral Excellence Programme Fellow at the Swiss Tropical and Public Health Institute (Swiss TPH). Her research focuses on clinical epidemiology and newborn and young child health and survival in low-resource settings and also on the development and testing of interventions to improve healthcare quality and appropriate antibiotic use for infants and young children. She is currently working on projects to develop and test novel electronic clinical decision support tools to improve the implementation of evidence-based medical care for young infants. Dr Levine has a master’s in public health from the Mailman School of Public Health at Columbia University and a PhD in epidemiology from the University of Washington, USA.

Dr Levine leads the BRCCH project: Electronic Clinical Decision Algorithms and Machine Learning to Improve Quality of Care and Clinical Outcomes for Sick Young Infants in Resource-Limited Countries. Read more here.

Dr Nigel Rollins joined the World Health Organization (WHO) Department of Maternal, Newborn, Child and Adolescent Health and Ageing in 2008 as a scientist and is currently the Acting Head of Research for the Department. His work focuses on research to improve child survival, growth and development. This includes implementation research related to infant feeding, prevention and management of growth faltering and wasting in children and the prevention of mother-to-child transmission of HIV. Prior to joining WHO, Dr Rollins was Professor in Maternal and Child Health at the University of KwaZulu-Natal (UKZN), Durban, South Africa, where he lived and worked for 14 years.

Dr Nicole Zoratto obtained her master’s degree in pharmaceutical chemistry and technologies at the Sapienza University of Rome, Italy, in 2016. Before graduating, she undertook her eight-month master’s research project at the Institute of Pharmaceutical Science at King’s College London, UK, under the supervision of Prof Cécile Dreiss. In the same year, she started her PhD in pharmaceutical science at the Sapienza University of Rome. Her research project focused on the development of innovative polysaccharide-based scaffolds for drug delivery applications. From November 2018 to August 2019, she was a visiting graduate researcher at the Khademhosseini laboratory at the California NanoSystems Institute at UCLA, USA, where her research project mainly focused on microfluidic-assisted particle formations, followed by particle annealing to develop soft and beaded-based scaffolds for tissue engineering applications. She earned her PhD in pharmaceutical sciences in December 2019 and then completed a year of postdoctoral research on polysaccharide-based hydrogels and nanogels in the Department of Chemistry and Technology of Drugs at the Sapienza University of Rome.

Dr Zoratto leads the BRCCH project: Bioinspired, Low-Cost Device for Minimally Invasive Blood Sampling. Read more here.

Dr. Nicole Stoffel received her BSc and MSc degrees in Pharmaceutical Sciences from ETH Zurich, Switzerland and completed her PhD in the Laboratory of Human Nutrition at ETH Zurich. She is currently a Group Leader in Nutritional Physiology and Therapeutics at the Botnar Research Centre at the University of Oxford and a Senior Scientist at the Laboratory of Nutrition and Metabolic Epigenetics at ETH Zurich. Dr. Stoffel was awarded the Swiss Foundation for Nutrition Research Award 2020 for her publications on oral iron supplementation in Lancet Hematology 2017 and in Haematologica 2019. She received the ETH Medal for her outstanding Doctoral thesis in 2018 and the James Mitchell Award for Excellence in Collaborative Science in 2023. In 2021 she was awarded the prestigious Lopez-Loreta Prize pour l’Exellence Académique for her research in the field of iron and adaptive immunity/vaccine response. Her current research interests are optimizing oral iron supplementation regimens in pregnant women, children and young infants and thereby also improving vaccine efficacy.

Prof Nissim Benvenisty is the Herbert Cohn Chair in Cancer Research and the Director of The Azrieli Center for Stem Cells and Genetic Research at the Hebrew University. He earned his M.D. and Ph.D. degrees from the Hebrew University, and conducted postdoctoral studies at Harvard University. Prof. Benvenisty’s research projects focus on stem cell biology, hereditary disorders, human genetics, and cancer research. He published numerous original and review papers on human pluripotent stem cells, and serves on the editorial board of various stem cell related journals. He is a member of the steering committee of the International Stem Cell Initiative (ISCI), the Programme Board of the UK–Regenerative Medical Platform (MRC), and serves as the academic advisor for the International Symposia of the International Society for Stem Cell Research (ISSCR). Prof. Benvenisty presents the issue of human embryonic stem cells in many international conferences, and gave testimonies before the US Senate and the European Union. He was awarded several prizes among them the Foulkes Prize (London), the Hestrin Prize, the Teva Prize, the Kaye Prize, the Milken Prize, the ACTO Award (Japan), The Azrieli Center Award (Canada) the Katzir Prize and the Rappaport Prize.